SANUWAVE Health, Inc. (SNWV): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2024-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$5.92M

Year ended 2025-12-31

$2.69M

Trailing 12 months to 2026-06-30

2019-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	$5.92M	+27.7%	2026-03-26, From 2025-01-01
2024-12-31	$4.64M	n/c	2026-03-26, From 2024-01-01
2023-12-31	$488.0K	n/m	2025-03-20, From 2023-01-01
2022-12-31	-$8.00M	n/m	2024-03-21, From 2022-01-01
2021-12-31	-$12.91M	n/m	2023-03-31, From 2021-01-01
2020-12-31	-$24.90M	n/m	2022-05-13, From 2020-01-01
2019-12-31	-$8.72M	n/a	2021-10-21, From 2019-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
SANUWAVE Health, Inc. (SNWV)	2025-12-31	$5.92M	+27.7%
TriSalus Life Sciences, Inc. (TLSI)	2025-12-31	-$26.32M	n/m
SS Innovations International, Inc. (SSII)	2025-12-31	-$7.12M	n/m
KORU Medical Systems, Inc. (KRMD)	2025-12-31	-$2.16M	n/m
Interpace Biosciences, Inc. (IDXG)	2025-12-31	$4.51M	-46.4%
Carlsmed, Inc. (CARL)	2025-12-31	-$30.29M	n/m
Retractable Technologies Inc (RVP)	2025-12-31	-$13.41M	n/m
Cytosorbents Corp (CTSO)	2025-12-31	-$13.52M	n/m
ClearPoint Neuro, Inc. (CLPT)	2025-12-31	-$23.35M	n/m

Compare SNWV, TLSI, SSII, KRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗